1409-4142
1409-4142
S1409-41422024000100016
CRI
CRI
CRI
CRI
00
12
2024
00
12
2024
26
1
16
24
[
2014
]
[
2017
70
(11)
(11)
991-1004
]
[
2021
42
(16)
(16)
1554-68
]
[
2022
24
^sSupplement_I
^sSupplement_I
Supplement_I
I131-8
]
[
2020
55
(5)
(5)
255-7
]
[
2024
331
(9)
(9)
778-91
]
[
2021
128
(10)
(10)
1554-75
]
[
2021
44
(3)
(3)
322-31
]
[
2004
30
(3)
(3)
178-81
]
[
2014
113
(10)
(10)
1723-7
]
[
2015
128
(12)
(12)
1275-80
]
[
2024
224
(5)
(5)
288-99
]
[
2021
110
(4)
(4)
479-506
]
[
2018
379
(11)
(11)
1007-16
]
[
2020
5
(3)
(3)
247-8
]
[
2024
]
[
2015
144
(9)
(9)
385-8
]
[
2008
]
[
2012
109
(24)
(24)
9629-34
]
[
2015
4
(2)
(2)
61-79
]
[
2012
421
(2)
(2)
185-203
]
[
1993
13
(3)
(3)
583-98
]
[
1993
77
(2)
(2)
370-4
]
[
1992
41
(1)
(1)
39-41
]
[
2012
79
(8)
(8)
785-92
]
[
2019
40
(45)
(45)
3699-706
]
[
2005
44
(25)
(25)
9265-74
]
[
2000
7
(4)
(4)
312-21
]
[
1990
]
[
2009
1-21
]
[
2001
98
(10)
(10)
5566-71
]
[
European Medicines Agency
]
[
2023
]
[
2022
60
(2)
(2)
]
[
2021
87
(9)
(9)
3574-87
]
[
2023
81
(03)
second edition
(03)
308-21
]
[
Pfizer
2020
]
[
2021
23
(2)
(2)
277-85
]
[
Lexidrug, UdToDate.
2024
]
[
]
[
2013
310
(24)
(24)
2658-67
]
[
2024
]
[
2016
7
(1)
(1)
10787
]
[
2021
288
(1)
(1)
310-24
]
[
2022
13
1
1
]
[
2014
]